These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
76 related articles for article (PubMed ID: 17302365)
41. Hepatitis C virus therapy in liver transplant recipients: response predictors, effect on fibrosis progression, and importance of the initial stage of fibrosis. Roche B; Sebagh M; Canfora ML; Antonini T; Roque-Afonso AM; Delvart V; Saliba F; Duclos-Vallee JC; Castaing D; Samuel D Liver Transpl; 2008 Dec; 14(12):1766-77. PubMed ID: 19025933 [TBL] [Abstract][Full Text] [Related]
42. A sustained virological response to interferon or interferon/ribavirin reduces hepatocellular carcinoma and improves survival in chronic hepatitis C: a nationwide, multicentre study in Taiwan. Yu ML; Lin SM; Chuang WL; Dai CY; Wang JH; Lu SN; Sheen IS; Chang WY; Lee CM; Liaw YF Antivir Ther; 2006; 11(8):985-94. PubMed ID: 17302368 [TBL] [Abstract][Full Text] [Related]
43. Optimizing treatment outcomes in chronic hepatitis C: management of non-response. Pol S; Bourlière M Antivir Ther; 2006; 11(8):955-70. PubMed ID: 17302365 [TBL] [Abstract][Full Text] [Related]
44. Treatment options for patients with hepatitis C: role of pharmacists in optimizing treatment response and managing adverse events. Smith JP Pharmacotherapy; 2008 Sep; 28(9):1151-61. PubMed ID: 18752386 [TBL] [Abstract][Full Text] [Related]
45. Retreatment of chronic hepatitis C virus infection in patients who failed to achieve sustained virologic response. Shiffman ML Minerva Gastroenterol Dietol; 2004 Mar; 50(1):37-49. PubMed ID: 15719005 [TBL] [Abstract][Full Text] [Related]
46. Interferons in the management of viral hepatitis. Zein NN Cytokines Cell Mol Ther; 1998 Dec; 4(4):229-41. PubMed ID: 10068057 [TBL] [Abstract][Full Text] [Related]
47. Management of chronic hepatitis C. Asselah T; Boyer N; Ripault MP; Martinot M; Marcellin P Minerva Gastroenterol Dietol; 2007 Mar; 53(1):9-23. PubMed ID: 17415342 [TBL] [Abstract][Full Text] [Related]
48. Managing chronic hepatitis C in relapsers and non-responders. Montalbano M; Kemmer N; Neff GW Minerva Gastroenterol Dietol; 2008 Mar; 54(1):31-47. PubMed ID: 18299666 [TBL] [Abstract][Full Text] [Related]
49. [HCV non-responder patients: definition of non-response and treatment strategy]. Marcellin P; Bourlière M; Pawlotsky JM; Ouzan D Gastroenterol Clin Biol; 2007; 31(8-9 Pt 3):4S13-9. PubMed ID: 17965630 [TBL] [Abstract][Full Text] [Related]
50. Review article: the treatment of hepatitis C virus recurrence after liver transplantation. Arjal RR; Burton JR; Villamil F; Rosen HR Aliment Pharmacol Ther; 2007 Jul; 26(2):127-40. PubMed ID: 17593060 [TBL] [Abstract][Full Text] [Related]
52. Management and therapy of chronic hepatitis C virus infection in HIV-infected individuals. Mauss S J HIV Ther; 2007 Mar; 12(1):11-7. PubMed ID: 17589391 [TBL] [Abstract][Full Text] [Related]
53. Current and future management of chronic hepatitis C infection. Cross TJ; Antoniades CG; Harrison PM Postgrad Med J; 2008 Apr; 84(990):172-6. PubMed ID: 18424572 [TBL] [Abstract][Full Text] [Related]
54. Treatment of chronic hepatitis C virus infection - Dutch national guidelines. de Bruijne J; Buster EH; Gelderblom HC; Brouwer JT; de Knegt RJ; van Erpecum KJ; Schalm SW; Bakker CM; Zaaijer HL; Janssen HL; Reesink HW; Neth J Med; 2008; 66(7):311-22. PubMed ID: 18663263 [TBL] [Abstract][Full Text] [Related]